Given its central role in energy metabolism, PGC-1α is a potential target for therapeutic interventions in metabolic diseases such as obesity, diabetes, and metabolic syndrome. Enhancing PGC-1α activity might improve mitochondrial function and energy expenditure, offering a strategy to combat these conditions.
